Literature DB >> 24152326

Future directions in the treatment of neuropathic pain: a review on various therapeutic targets.

Matharasala Gangadhar, Ram Kumar Mishra, Dharmarajan Sriram, Perumal Yogeeswari1.   

Abstract

Neuropathic pain is caused by structural lesion leading to functional abnormalities in central and peripheral nervous system. Neuropathic pain in itself is not always a disease, as it arises due to consequences of other diseases like diabetes, spinal cord injury, degenerative neuronal diseases and cancer. Current strategies of neuropathic pain treatment have provided relief to the patients to some extent, but complete cure is still a distant dream. In the future, it is hoped that a combination of new and improved pharmaceutical developments combined with careful clinical trials and increased understanding of neuroplasticity will lead to improved and effective pain management strategies leading to improved quality of life. In this review we have discussed various therapeutic targets of neuropathic pain and their pathophysiological mechanisms. Current status of drugs used for treatment of neuropathic pain have also been discussed in the review.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24152326     DOI: 10.2174/18715273113126660192

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  5 in total

Review 1.  Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation.

Authors:  Domenico Intiso; Mario Basciani; Andrea Santamato; Marta Intiso; Filomena Di Rienzo
Journal:  Toxins (Basel)       Date:  2015-06-30       Impact factor: 4.546

2.  Effect of Wnt signaling pathway on pathogenesis and intervention of neuropathic pain.

Authors:  Yu Zhao; Zhanyun Yang
Journal:  Exp Ther Med       Date:  2018-07-23       Impact factor: 2.447

3.  The effects of botulinum toxin type A injection on pain symptoms, quality of life, and sleep quality of patients with diabetic neuropathy: A randomized double-blind clinical trial.

Authors:  Hossein Salehi; Moein Moussaei; Zahra Kamiab; Alireza Vakilian
Journal:  Iran J Neurol       Date:  2019-07-06

4.  Scorpion Toxin, BmP01, Induces Pain by Targeting TRPV1 Channel.

Authors:  Md Abdul Hakim; Wenbin Jiang; Lei Luo; Bowen Li; Shilong Yang; Yuzhu Song; Ren Lai
Journal:  Toxins (Basel)       Date:  2015-09-14       Impact factor: 4.546

5.  MAPK Pathways Are Involved in Neuropathic Pain in Rats with Chronic Compression of the Dorsal Root Ganglion.

Authors:  Yu-Juan Qu; Lei Jia; Xiao Zhang; Hui Wei; Shou-Wei Yue
Journal:  Evid Based Complement Alternat Med       Date:  2016-07-18       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.